OPPM
GEVA

Opus Point Partners Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Opus Point Partners Management’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-17,700
Closed -$1.73M – 72
2015
Q1 		$1.73M Sell
17,700
-2,302
-12% -$244K 1.45% 25
2014
Q4 		$1.86M Buy
+20,002
New +$1.58M 1.84% 24

Opus Point Partners Management's GEVA Position: Q2 2015 in Review

Opus Point Partners Management sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 17,700 shares — an estimated $1.73M sold.

Opus Point Partners Management first reported a position in GEVA in Q4 2014 and held it in 2 quarters. The position peaked at $1.86M in Q4 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Opus Point Partners Management reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Opus Point Partners Management sold 17,700 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $1.73M.
  • Opus Point Partners Management first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • Opus Point Partners Management's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.86M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Opus Point Partners Management's 13F filing for Q2 2015, filed 14 Aug 2015.